FindTrial
Sign In

Cervical myofascial trigger point injection for the treatment of persistent moderate to severe allergic rhinitis and asthma in adults

Cervical myofascial trigger point injection for the treatment of persistent moderate to severe allergic rhinitis and asthma in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020590
Enrollment
Unknown
Registered
2019-01-09
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis, asthma

Interventions

Case series:Myofascial trigger point injection

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults with allergic rhinitis and/or asthma have received or have not received firstline treatment in current clinical guidelines.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. People who are allergic to one or more components of the potion; 3. Patients with cardiopulmonary insufficiency; 4. People not suitable to participate in the study for other reasons not mentioned.

Design outcomes

Primary

MeasureTime frame
Sysptom score;—

Countries

China

Contacts

Public ContactFeng Qi

Qilu Hospital of Shandong University

qifeng66321@sina.com+86 18560083756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026